Stock screenerAll disclosures → EDGAR →
DYAI
Conviction 20HealthcareScan · Thu, Jun 25, 2026DYAI$0.7410+1.37%
ResistanceSupportVol 14Vol MA14 277.15K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.7410
Change+1.37%
Gap+9.45%
Rel volume3.32×
Avg volume720.08K
Avg $ vol522.55K
SMA 200.7428
SMA 500.7654
SMA 2000.8948
Price vs 50-3.19%
Price vs 200-17.19%
MA stackbearish
50/200 cross—
Supertrenddown · 0.8717
RSI (14)49
MACD hist0.00
MACD crossbull · 7d
Stoch %K / %D36 / 44
ADX (14)24
+DI / −DI20 / 14
RSI divergence—
MACD divergence—
ATR %+9.81%
ADR %9.95%
52w high1.30
52w low0.6754
From 52w high-43.00%
Above 52w low+9.71%
New 52w highNo
SqueezeOff
Bollinger width26.70%
%B0.49
Donchian pos36.11%
Donchian high0.8900
Donchian low0.6568
AVWAP (52w high)0.8559
vs AVWAP high-13.42%
AVWAP (52w low)0.7413
vs AVWAP low-0.04%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d3.32×
Avg vol (14d)277.15K
Avg vol (20d)720.08K
Avg $ vol (20d)522.55K
Market cap27M
RS 3m (vs SPY)-25.70%
RS 6m (vs SPY)-34.62%
RS line new highNo
Trend template0/8
Technical rank22.6
1 week-12.68%
1 month-1.85%
3 months-15.07%
6 months-25.89%
1 year-24.83%
YTD-21.16%
P/E-3.67
P/B-66.22
P/S8.74
P/FCF—
EPS-0.2300
Div yield—
ROE—
ROA-94.30%
Debt/Eq—
Current2.42
EV/EBITDA—
Gross margin—
Net margin-238.31%
Rev growth-11.59%
EPS growth-26.78%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value22.75M
Revenue1.11M
Net income-1.95M
Gross profit—
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out36.44M
Employees5
ListedFri, Nov 5, 2004
Free float26.98M
Float %74.0%
Short interest622.47K
Days to cover0.6d
Short volume54.3%
Squeeze score32 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank22.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.8600
Support0.6634
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DYAI
No recent disclosed trades by Congress in DYAI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DYAI
No recent insider (Form 4) filings in DYAI. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in DYAI · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.